Connection

George Lau to Non-alcoholic Fatty Liver Disease

Back to Details
This is a "connection" page, showing publications George Lau has written about Non-alcoholic Fatty Liver Disease.
George Lau
Connection Strength
2.165
Non-alcoholic Fatty Liver Disease
  1. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19. Metabolism. 2021 02; 115:154437.
    View in: PubMed
    Score: 0.438
  2. Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues". J Hepatol. 2021 02; 74(2):484-485.
    View in: PubMed
    Score: 0.436
  3. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020 Sep; 14(5):701-710.
    View in: PubMed
    Score: 0.429
  4. Reply to: 'NAFLD or comorbidities, that is the question'. J Hepatol. 2020 09; 73(3):724-725.
    View in: PubMed
    Score: 0.422
  5. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 08; 73(2):451-453.
    View in: PubMed
    Score: 0.419
  6. ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives. Horm Metab Res. 2017 May; 49(5):343-349.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.